Current issue
Archive
Manuscripts accepted
About the journal
Editorial board
Abstracting and indexing
Contact
Instructions for authors
Ethical standards and procedures
Editorial System
Submit your Manuscript
|
1/2017
vol. 82 abstract:
Original paper
Role of Contrast Enhancement and Corrected Attenuation Values of Renal Tumors in Predicting Renal Cell Carcinoma (RCC) Subtypes: Protocol for a Triphasic Multi-Slice Computed Tomography (CT) Procedure
Ersen Ertekin
,
Akın Soner Amasyalı
,
Bulent Erol
,
Saim Acikgozoglu
,
Faruk Kucukdurmaz
,
Alaaddin Nayman
,
Haluk Erol
Pol J Radiol, 2017; 82: 384-391
Online publish date: 2018/02/02
View full text
Get citation
ENW EndNote
BIB JabRef, Mendeley
RIS Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
Background: To distinguish RCC subtypes based on contrast enhancement features of CT images.
Material/Methods: In total, 59 lesions from 57 patients were included. All patients underwent multi-slice CT imaging with a triphasic protocol, which included non-contrast, corticomedullary, nephrographic and urographic phases. Contrast enhancement features of renal masses were evaluated in terms of CT attenuation values (AV) and differences in contrast density; the aorta or renal parenchyma were evaluated based on corrected or relative values. Results: Clear cell RCC (ccRCC) showed more intense contrast enhancement than other RCC subtypes. When differentiating ccRCC from other RCC subtypes, a cut-off AV of 86–89 HU, aorta-based corrected AV of 89–95 HU and renal parenchyma-based corrected AV of 87-95 HU showed a diagnostic accuracy of 81–86%, 86–88% and 74–78%, respectively, in the corticomedullary phase. Furthermore, a cutoff of 2.42–2.72 for the relative contrast enhancement ratio, a cutoff of 2.59–2.74 for the aorta-based corrected relative contrast enhancement ratio and a cutoff of 2.63–2.76 for the renal parenchymabased attenuation ratio showed a diagnostic accuracy of 83–88%, 88–90% and 81%, respectively. Conclusions: The most reliable parameters for differentiating ccRCC from other RCC subtypes are aortabased corrected AV and aorta-based corrected relative contrast enhancement values in the corticomedullary phase. keywords:
Carcinoma, Renal Cell • Contrast Media • Multidetector Computed Tomography |